• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Risk score overestimation: the impact of individual cardiovascular risk factors and preventive therapies on the performance of the American Heart Association-American College of Cardiology-Atherosclerotic Cardiovascular Disease risk score in a modern multi-ethnic cohort.风险评分高估:个体心血管危险因素及预防性治疗对美国心脏协会 - 美国心脏病学会 - 动脉粥样硬化性心血管疾病风险评分在现代多民族队列中表现的影响
Eur Heart J. 2017 Feb 21;38(8):598-608. doi: 10.1093/eurheartj/ehw301.
2
Prevalence and Trends in Cardiovascular Risk Factors Among Middle Aged Persons from Five Race and Ethnic Groups in the United States: A Longitudinal Analysis of Two Cohort Studies.美国五个种族和族裔中年人群心血管危险因素的患病率及趋势:两项队列研究的纵向分析
medRxiv. 2024 Sep 28:2024.09.27.24314520. doi: 10.1101/2024.09.27.24314520.
3
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
4
Applicability and Risk Stratification of QRISK®, Framingham Risk Score, Systematic Coronary Risk Evaluation (SCORE), and American College of Cardiology/American Heart Association (ACC/AHA) Risk Assessment Tools Among Patients in Taif, Saudi Arabia.QRISK®、弗雷明汉风险评分、系统性冠状动脉风险评估(SCORE)以及美国心脏病学会/美国心脏协会(ACC/AHA)风险评估工具在沙特阿拉伯塔伊夫患者中的适用性及风险分层
Cureus. 2025 Jun 28;17(6):e86910. doi: 10.7759/cureus.86910. eCollection 2025 Jun.
5
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
6
An analysis of calibration and discrimination among multiple cardiovascular risk scores in a modern multiethnic cohort.现代多民族队列中多种心血管风险评分的校准与鉴别分析。
Ann Intern Med. 2015 Feb 17;162(4):266-75. doi: 10.7326/M14-1281.
7
Performance of the pooled cohort equations and D:A:D risk scores among individuals with HIV in a global cardiovascular disease prevention trial: a cohort study leveraging data from REPRIEVE.在一项全球心血管疾病预防试验中,对感染艾滋病毒个体应用汇总队列方程和D:A:D风险评分的情况:一项利用REPRIEVE研究数据的队列研究
Lancet HIV. 2025 Feb;12(2):e118-e129. doi: 10.1016/S2352-3018(24)00276-5. Epub 2025 Jan 17.
8
Racial and ethnic disparities in fecundability: a North American preconception cohort study.生育力方面的种族和族裔差异:一项北美孕前队列研究。
Hum Reprod. 2025 Apr 17. doi: 10.1093/humrep/deaf067.
9
Tailoring Risk Prediction Models to Local Populations.针对当地人群定制风险预测模型。
JAMA Cardiol. 2024 Nov 1;9(11):1018-1028. doi: 10.1001/jamacardio.2024.2912.
10
Surveillance for Violent Deaths - National Violent Death Reporting System, 50 States, the District of Columbia, and Puerto Rico, 2022.暴力死亡监测——2022年全国暴力死亡报告系统,50个州、哥伦比亚特区和波多黎各
MMWR Surveill Summ. 2025 Jun 12;74(5):1-42. doi: 10.15585/mmwr.ss7405a1.

引用本文的文献

1
Atherosclerotic Cardiovascular Disease Risk Estimates Using the New Predicting Risk of Cardiovascular Disease Events Equations: Implications for Statin Use.使用新的心血管疾病事件风险预测方程评估动脉粥样硬化性心血管疾病风险:对他汀类药物使用的影响
Curr Cardiol Rep. 2025 Jul 2;27(1):107. doi: 10.1007/s11886-025-02244-5.
2
PREVENT Risk Score vs the Pooled Cohort Equations in MESA.MESA研究中PREVENT风险评分与合并队列方程的比较
JACC Adv. 2025 May 26;4(6 Pt 1):101825. doi: 10.1016/j.jacadv.2025.101825.
3
Relationship Between Metabolic Age Determined by Bioimpedance and Insulin Resistance Risk Scales in Spanish Workers.西班牙工人中生物电阻抗测定的代谢年龄与胰岛素抵抗风险量表之间的关系
Nutrients. 2025 Mar 8;17(6):945. doi: 10.3390/nu17060945.
4
Assessing cardiovascular disease risk and social determinants of health: A comparative analysis of five risk estimation instruments using data from the Eastern Caribbean Health Outcomes Research Network.评估心血管疾病风险和健康的社会决定因素:使用东加勒比健康结果研究网络的数据对五种风险评估工具进行比较分析。
PLoS One. 2025 Jan 24;20(1):e0316577. doi: 10.1371/journal.pone.0316577. eCollection 2025.
5
Updates on CAD risk assessment: using the coronary artery calcium score in combination with traditional risk factors.冠心病风险评估的最新进展:冠状动脉钙化评分与传统风险因素的联合应用。
Egypt Heart J. 2025 Jan 23;77(1):14. doi: 10.1186/s43044-025-00608-4.
6
Development and validation of a five-year cardiovascular risk assessment tool for Asian adults aged 75 years and older.针对75岁及以上亚洲成年人的五年心血管风险评估工具的开发与验证
BMC Geriatr. 2025 Jan 8;25(1):15. doi: 10.1186/s12877-024-05660-4.
7
Differences in Statin Eligibility With the Use of Predicting Risk of Cardiovascular Disease EVENTs Versus Pooled Cohort Equations in the UK Biobank.在英国生物银行中,使用心血管疾病事件预测风险与合并队列方程时他汀类药物适用情况的差异。
Am J Cardiol. 2025 Apr 15;241:43-51. doi: 10.1016/j.amjcard.2024.12.034. Epub 2025 Jan 3.
8
Structural and social determinants of health: The multi-ethnic study of atherosclerosis.健康的结构和社会决定因素:动脉粥样硬化的多种族研究。
PLoS One. 2024 Nov 18;19(11):e0313625. doi: 10.1371/journal.pone.0313625. eCollection 2024.
9
Cardiovascular Computed Tomography and Magnetic Resonance Imaging Guideline of the Brazilian Society of Cardiology and the Brazilian College of Radiology - 2024.巴西心脏病学会和巴西放射学会心血管计算机断层扫描与磁共振成像指南 - 2024年
Arq Bras Cardiol. 2024 Oct 28;121(9):e20240608. doi: 10.36660/abc.20240608.
10
Risk-enhancing factors and social determinants of health in risk assessment for atherosclerotic cardiovascular disease.动脉粥样硬化性心血管疾病风险评估中的风险增强因素和健康的社会决定因素。
PLoS One. 2024 Oct 25;19(10):e0312756. doi: 10.1371/journal.pone.0312756. eCollection 2024.

本文引用的文献

1
Accuracy of the Atherosclerotic Cardiovascular Risk Equation in a Large Contemporary, Multiethnic Population.当代大型多民族人群中动脉粥样硬化性心血管疾病风险方程的准确性
J Am Coll Cardiol. 2016 May 10;67(18):2118-2130. doi: 10.1016/j.jacc.2016.02.055.
2
Demographic and epidemiologic drivers of global cardiovascular mortality.全球心血管疾病死亡率的人口统计学和流行病学驱动因素。
N Engl J Med. 2015 Apr 2;372(14):1333-41. doi: 10.1056/NEJMoa1406656.
3
An analysis of calibration and discrimination among multiple cardiovascular risk scores in a modern multiethnic cohort.现代多民族队列中多种心血管风险评分的校准与鉴别分析。
Ann Intern Med. 2015 Feb 17;162(4):266-75. doi: 10.7326/M14-1281.
4
Prescription cholesterol-lowering medication use in adults aged 40 and over: United States, 2003-2012.2003 - 2012年美国40岁及以上成年人使用处方降胆固醇药物的情况
NCHS Data Brief. 2014 Dec(177):1-8.
5
Further insight into the cardiovascular risk calculator: the roles of statins, revascularizations, and underascertainment in the Women's Health Study.进一步深入了解心血管风险计算器:他汀类药物、血运重建术和妇女健康研究中的信息不足在其中所扮演的角色。
JAMA Intern Med. 2014 Dec;174(12):1964-71. doi: 10.1001/jamainternmed.2014.5336.
6
Validation of the atherosclerotic cardiovascular disease Pooled Cohort risk equations.验证动脉粥样硬化性心血管疾病的汇总队列风险方程。
JAMA. 2014 Apr 9;311(14):1406-15. doi: 10.1001/jama.2014.2630.
7
Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort.比较 ACC/AHA 指南、成人治疗专家组 III 指南和欧洲心脏病学会指南在欧洲队列中用于心血管疾病预防的应用。
JAMA. 2014 Apr 9;311(14):1416-23. doi: 10.1001/jama.2014.2632.
8
Statins: new American guidelines for prevention of cardiovascular disease.他汀类药物:美国预防心血管疾病的新指南
Lancet. 2013 Nov 30;382(9907):1762-5. doi: 10.1016/S0140-6736(13)62388-0. Epub 2013 Nov 20.
9
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.2013年美国心脏病学会/美国心脏协会心血管风险评估指南:美国心脏病学会/美国心脏协会实践指南工作组报告
Circulation. 2014 Jun 24;129(25 Suppl 2):S49-73. doi: 10.1161/01.cir.0000437741.48606.98. Epub 2013 Nov 12.
10
Multiple imputation using chained equations: Issues and guidance for practice.使用链式方程进行多重插补:实践中的问题和指导。
Stat Med. 2011 Feb 20;30(4):377-99. doi: 10.1002/sim.4067. Epub 2010 Nov 30.

风险评分高估:个体心血管危险因素及预防性治疗对美国心脏协会 - 美国心脏病学会 - 动脉粥样硬化性心血管疾病风险评分在现代多民族队列中表现的影响

Risk score overestimation: the impact of individual cardiovascular risk factors and preventive therapies on the performance of the American Heart Association-American College of Cardiology-Atherosclerotic Cardiovascular Disease risk score in a modern multi-ethnic cohort.

作者信息

DeFilippis Andrew Paul, Young Rebekah, McEvoy John W, Michos Erin D, Sandfort Veit, Kronmal Richard A, McClelland Robyn L, Blaha Michael J

机构信息

Jewish Hospital, Louisville, KY, USA.

Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Baltimore, MD, USA.

出版信息

Eur Heart J. 2017 Feb 21;38(8):598-608. doi: 10.1093/eurheartj/ehw301.

DOI:10.1093/eurheartj/ehw301
PMID:27436865
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5837662/
Abstract

AIMS

To evaluate the 2013 American Heart Association (AHA)-American College of Cardiology (ACC)-Atherosclerotic Cardiovascular Disease (ASCVD) risk score among four different race/ethnic groups and to ascertain which factors are most associated with risk overestimation by the AHA-ACC-ASCVD score.

METHODS AND RESULTS

The Multi-Ethnic Study of Atherosclerosis (MESA), a prospective community-based cohort, was used to examine calibration and discrimination of the AHA-ACC-ASCVD risk score in 6441 White, Black, Chinese, and Hispanic Americans (aged 45-79 years and free of known ASCVD at baseline). Using univariable and multivariable absolute risk regression, we modelled the impact of individual risk factors on the discordance between observed and predicted 10-year ASCVD risk. Overestimation was observed in all race/ethnic groups in MESA and was highest among Chinese (252% for women and 314% for men) and lowest in White women (72%) and Hispanic men (67%). Higher age, Chinese race/ethnicity (when compared with White), systolic blood pressure (treated and untreated), diabetes, alcohol use, exercise, lipid-lowering medication, and aspirin use were all associated with more risk overestimation, whereas family history was associated with less risk overestimation in a multivariable model (all P < 0.05).

CONCLUSION

The AHA-ACC-ASCVD risk score overestimates ASCVD risk among men, women, and all four race/ethnic groups evaluated in a modern American primary prevention cohort. Clinicians treating patients similar to those in MESA, particularly older individuals and those with factors associated with more risk overestimation, may consider interpreting absolute ASCVD risk estimates with caution.

摘要

目的

评估2013年美国心脏协会(AHA)-美国心脏病学会(ACC)-动脉粥样硬化性心血管疾病(ASCVD)风险评分在四个不同种族/族裔群体中的情况,并确定哪些因素与AHA-ACC-ASCVD评分高估风险最为相关。

方法与结果

动脉粥样硬化多民族研究(MESA)是一项基于社区的前瞻性队列研究,用于检验AHA-ACC-ASCVD风险评分在6441名白人、黑人、华裔和西班牙裔美国人(年龄45 - 79岁,基线时无已知ASCVD)中的校准和区分能力。使用单变量和多变量绝对风险回归,我们模拟了个体风险因素对观察到的和预测的10年ASCVD风险之间不一致性的影响。在MESA的所有种族/族裔群体中均观察到风险高估情况,其中华裔最高(女性为252%,男性为314%),白人女性(72%)和西班牙裔男性(67%)最低。年龄较大、华裔种族/族裔(与白人相比)、收缩压(治疗和未治疗)、糖尿病、饮酒、运动、降脂药物使用和阿司匹林使用均与更多的风险高估相关,而在多变量模型中家族史与较少的风险高估相关(所有P < 0.05)。

结论

AHA-ACC-ASCVD风险评分高估了现代美国一级预防队列中评估的男性、女性以及所有四个种族/族裔群体的ASCVD风险。治疗与MESA中患者相似的临床医生,尤其是老年个体以及那些具有与更多风险高估相关因素的患者,可能需要谨慎解读绝对ASCVD风险估计值。